ECSP10010514A - Formulaciones mejoradas para ingredientes farmaceuticos activos de permeabilidad deficiente - Google Patents
Formulaciones mejoradas para ingredientes farmaceuticos activos de permeabilidad deficienteInfo
- Publication number
- ECSP10010514A ECSP10010514A EC2010010514A ECSP10010514A ECSP10010514A EC SP10010514 A ECSP10010514 A EC SP10010514A EC 2010010514 A EC2010010514 A EC 2010010514A EC SP10010514 A ECSP10010514 A EC SP10010514A EC SP10010514 A ECSP10010514 A EC SP10010514A
- Authority
- EC
- Ecuador
- Prior art keywords
- permeability
- active pharmaceutical
- deficient
- pharmaceutical ingredients
- improved formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invencion se relaciona con una forma de dosificacion oral farmaceutica que contiene un ingrediente farmaceutico activo de permeabilidad deficiente y al menos una sustancia mejoradora de permeabilidad, en donde la sustancia mejoradora de permeabilidad se incorpora en forma termoestable a una matriz soluble en agua de un portador soluble en agua y con formulaciones termoestables que se pueden usar para mejorar la biodisponibilidad.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08103657 | 2008-04-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP10010514A true ECSP10010514A (es) | 2010-11-30 |
Family
ID=39816874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2010010514A ECSP10010514A (es) | 2008-04-22 | 2010-10-01 | Formulaciones mejoradas para ingredientes farmaceuticos activos de permeabilidad deficiente |
Country Status (18)
Country | Link |
---|---|
US (1) | US20090263479A1 (es) |
EP (1) | EP2268270A2 (es) |
JP (1) | JP5726067B2 (es) |
KR (1) | KR20110005883A (es) |
CN (1) | CN102119025B (es) |
AR (1) | AR071375A1 (es) |
AU (1) | AU2009240050A1 (es) |
BR (1) | BRPI0910758A2 (es) |
CA (1) | CA2720658C (es) |
CO (1) | CO6300932A2 (es) |
DO (1) | DOP2010000318A (es) |
EA (1) | EA032766B1 (es) |
EC (1) | ECSP10010514A (es) |
IL (1) | IL208370A0 (es) |
MX (1) | MX2010011564A (es) |
NZ (1) | NZ588369A (es) |
TW (1) | TW200948399A (es) |
WO (1) | WO2009130204A2 (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
AR071375A1 (es) | 2008-04-22 | 2010-06-16 | Solvay Pharm Gmbh | Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto |
EP2911651B1 (en) | 2012-09-27 | 2016-06-22 | Basf Se | A storage-stable dust-free homogeneous particulate formulation comprising at least one water-soluble vitamin e-derivative and at least one hydrophilic polymer |
JP6275726B2 (ja) | 2012-09-27 | 2018-02-07 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | 少なくとも1種の水溶性ビタミンe誘導体および少なくとも1種の親水性ポリマーを含む、保存において安定な無塵の均質な粒子製剤 |
US9744240B2 (en) | 2012-09-27 | 2017-08-29 | Basf Se | Storage-stable dust-free homogeneous particulate formulation comprising at least one water-soluble vitamin E-derivative and at least one hydrophilic polymer |
US9789063B2 (en) | 2012-09-27 | 2017-10-17 | Basf Se | Storage-stable dust-free homogeneous particulate formulation |
HUE047749T2 (hu) * | 2013-02-06 | 2020-05-28 | Hermes Arzneimittel Gmbh | Gyógyszereket alacsony dózisban tartalmazó gyógyászati készítmények |
KR102379639B1 (ko) * | 2014-06-18 | 2022-03-28 | 에프. 호프만-라 로슈 아게 | 비이온성 계면활성제를 포함하는 약학 조성물 |
US10314801B2 (en) | 2014-06-20 | 2019-06-11 | Hermes Arzneimittel Gmbh | Taste-masked oral pharmaceutical composition |
CN111053755B (zh) * | 2019-12-31 | 2022-03-29 | 金日制药(中国)有限公司 | 一种高渗透性的头孢克肟胶囊制剂制备方法 |
EP4122483A4 (en) * | 2020-03-18 | 2024-03-27 | Xizang Haisco Pharmaceutical Co., Ltd. | ORAL PHARMACEUTICAL COMPOSITION |
CN112704649A (zh) * | 2020-12-30 | 2021-04-27 | 广东臻香荟生物科技有限公司 | 一种具备抑菌性能的香薰液 |
JP7368548B2 (ja) * | 2021-07-02 | 2023-10-24 | 昊運股▲フン▼有限公司 | 薬学的組成物及びその使用 |
CN114601800B (zh) * | 2021-09-28 | 2023-07-28 | 天津瑞普生物技术股份有限公司 | 一种甲磷丙泊酚钠无菌粉针剂及其制备方法 |
WO2023168089A2 (en) * | 2022-03-04 | 2023-09-07 | Abitec Corporation | Tablet dosage forms for lipid-based drug delivery systems |
WO2023174433A1 (en) * | 2022-03-18 | 2023-09-21 | Smart Pharmaceutical (Suzhou) Co., Ltd. | Solid, semisolid, or liquid compositions for augmenting the stability, permeability and bioavailability of active pharmaceutical substances |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2921883A (en) * | 1957-05-03 | 1960-01-19 | Smith Kline French Lab | Novel coating material for medicaments |
US3145146A (en) * | 1961-10-31 | 1964-08-18 | Warner Lambert Pharmaceutical | Modified mannitol for pharmaceutical tablets |
US3477864A (en) * | 1965-05-07 | 1969-11-11 | Sumitomo Chemical Co | Process for coating pharmaceutical preparations with a hydroxy propyl methyl cellulose-sealing agent moisture-preventing film |
US3692543A (en) * | 1971-01-28 | 1972-09-19 | Wellman Lord Inc | Food products |
JPS57171428A (en) * | 1981-04-13 | 1982-10-22 | Sankyo Co Ltd | Preparation of coated solid preparation |
JPH085086B2 (ja) * | 1992-07-14 | 1996-01-24 | メリート株式会社 | 金型装置 |
DE19709532A1 (de) * | 1997-03-10 | 1998-09-17 | Basf Ag | Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten zum Überziehen von pharmazeutischen oder agrochemischen Darreichungsformen |
FR2790388B1 (fr) * | 1999-03-04 | 2001-04-13 | Synthelabo | Compositions pharmaceutiques comprenant un benzamide et au moins un promoteur d'absorption |
DE19913606A1 (de) * | 1999-03-25 | 2000-09-28 | Basf Ag | Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen |
DE10046541A1 (de) | 2000-09-19 | 2002-03-28 | Knoll Ag | Mechanisch stabile darreichungsformen, enthaltend Ubichinone |
US6692771B2 (en) | 2001-02-23 | 2004-02-17 | Cima Labs Inc. | Emulsions as solid dosage forms for oral administration |
KR100425226B1 (ko) * | 2001-07-03 | 2004-03-30 | 주식회사 팜트리 | 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법 |
AR038681A1 (es) * | 2002-02-14 | 2005-01-26 | Solvay Pharm Bv | Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua |
SI1476138T1 (sl) * | 2002-02-21 | 2012-07-31 | Valeant Internat Barbados Srl | Formulacije s prirejenim sproščanjem vsaj ene oblike tramadola |
US6962006B2 (en) * | 2002-12-19 | 2005-11-08 | Acusphere, Inc. | Methods and apparatus for making particles using spray dryer and in-line jet mill |
WO2004062692A1 (en) * | 2003-01-13 | 2004-07-29 | Solvay Pharmaceuticals B.V. | Formulation of poorly water-soluble active substances |
SA04250283B1 (ar) * | 2003-09-26 | 2008-05-26 | سولفاي فارماسيتيكالز جي أم بي أتش | مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid |
US7262184B2 (en) * | 2003-09-26 | 2007-08-28 | Solvay Pharmaceuticals Gmbh | Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing them |
US20070065513A1 (en) * | 2003-10-31 | 2007-03-22 | Avi Avramoff | Stable lansoprazole formulation |
EP1799194B1 (en) * | 2004-09-24 | 2011-11-16 | Boehringer Ingelheim Pharmaceuticals Inc. | A new class of surfactant-like materials comprising vitamin e tpgs and a water soluble polymer |
US20060240108A1 (en) * | 2005-04-26 | 2006-10-26 | Bernard Bobby L | Cellulosic films incorporating a pharmaceutically acceptable plasticizer with enhanced wettability |
FR2886293B1 (fr) * | 2005-05-30 | 2007-08-24 | Fournier S A Sa Lab | Nouveaux composes de l'indoline |
WO2006133733A1 (en) * | 2005-06-13 | 2006-12-21 | Flamel Technologies | Oral dosage form comprising an antimisuse system |
WO2007086078A2 (en) * | 2006-01-30 | 2007-08-02 | Panacea Biotec Ltd. | Novel pharmaceutical compositions and process of preparation thereof |
CA2641451C (en) * | 2006-02-09 | 2012-10-02 | Merck & Co., Inc. | Polymer formulations of cetp inhibitors |
US20070292512A1 (en) | 2006-06-09 | 2007-12-20 | Merrion Research Ii Limited | Solid Oral Dosage Form Containing an Enhancer |
AU2007312233B2 (en) * | 2006-10-20 | 2012-09-20 | Abbvie B.V. | Micellar nanoparticles of chemical substances |
US7923026B2 (en) * | 2006-10-20 | 2011-04-12 | Solvay Pharmaceuticals B.V. | Embedded micellar nanoparticles |
US20070172525A1 (en) * | 2007-03-15 | 2007-07-26 | Ramesh Sesha | Anti-diabetic combinations |
AR071375A1 (es) | 2008-04-22 | 2010-06-16 | Solvay Pharm Gmbh | Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto |
-
2009
- 2009-04-17 AR ARP090101363A patent/AR071375A1/es not_active Application Discontinuation
- 2009-04-20 TW TW098112984A patent/TW200948399A/zh unknown
- 2009-04-21 CA CA2720658A patent/CA2720658C/en active Active
- 2009-04-21 EP EP09733920A patent/EP2268270A2/en not_active Withdrawn
- 2009-04-21 CN CN200980114260.9A patent/CN102119025B/zh not_active Expired - Fee Related
- 2009-04-21 JP JP2011505485A patent/JP5726067B2/ja not_active Expired - Fee Related
- 2009-04-21 MX MX2010011564A patent/MX2010011564A/es active IP Right Grant
- 2009-04-21 BR BRPI0910758A patent/BRPI0910758A2/pt not_active IP Right Cessation
- 2009-04-21 WO PCT/EP2009/054720 patent/WO2009130204A2/en active Application Filing
- 2009-04-21 US US12/427,144 patent/US20090263479A1/en not_active Abandoned
- 2009-04-21 NZ NZ588369A patent/NZ588369A/en not_active IP Right Cessation
- 2009-04-21 EA EA201071218A patent/EA032766B1/ru not_active IP Right Cessation
- 2009-04-21 AU AU2009240050A patent/AU2009240050A1/en not_active Abandoned
- 2009-04-21 KR KR1020107026033A patent/KR20110005883A/ko not_active Application Discontinuation
-
2010
- 2010-10-01 EC EC2010010514A patent/ECSP10010514A/es unknown
- 2010-10-03 IL IL208370A patent/IL208370A0/en unknown
- 2010-10-21 DO DO2010000318A patent/DOP2010000318A/es unknown
- 2010-10-25 CO CO10131897A patent/CO6300932A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EA201071218A1 (ru) | 2011-06-30 |
KR20110005883A (ko) | 2011-01-19 |
CN102119025B (zh) | 2014-09-03 |
EA032766B1 (ru) | 2019-07-31 |
BRPI0910758A2 (pt) | 2018-03-20 |
JP2011518208A (ja) | 2011-06-23 |
IL208370A0 (en) | 2010-12-30 |
CA2720658C (en) | 2016-07-12 |
WO2009130204A3 (en) | 2010-08-05 |
MX2010011564A (es) | 2011-03-02 |
CO6300932A2 (es) | 2011-07-21 |
TW200948399A (en) | 2009-12-01 |
CN102119025A (zh) | 2011-07-06 |
AR071375A1 (es) | 2010-06-16 |
AU2009240050A1 (en) | 2009-10-29 |
CA2720658A1 (en) | 2009-10-29 |
NZ588369A (en) | 2012-06-29 |
WO2009130204A2 (en) | 2009-10-29 |
JP5726067B2 (ja) | 2015-05-27 |
EP2268270A2 (en) | 2011-01-05 |
DOP2010000318A (es) | 2011-01-15 |
US20090263479A1 (en) | 2009-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP10010514A (es) | Formulaciones mejoradas para ingredientes farmaceuticos activos de permeabilidad deficiente | |
CR11625A (es) | Formulacion de capsula | |
TN2010000152A1 (en) | Pharmaceutical compositions | |
PE20140960A1 (es) | Formulaciones que comprenden un inhibidor de dpp4 | |
UA106636C2 (uk) | Морфолінотіазоли як позитивні алостеричні модулятори альфа 7 | |
ECSP088889A (es) | Forma nueva de administración de racecadotril | |
TR200900878A2 (tr) | Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar | |
BR122020011180B8 (pt) | formulações injetáveis de compostos de tetraciclina | |
GT200800297A (es) | Formulaciones galenicas de alisquireno e hidroclorotiazida | |
EA201270745A1 (ru) | Улучшенный стабильный водный состав (e)-4-карбоксистирил-4-хлорбензилсульфона | |
TR200806300A2 (tr) | Çözünürlük artırıcı farmasötlk formulasyon | |
EA201170269A1 (ru) | Композиция для предотвращения или замедления развития рака предстательной железы | |
IN2014DN10134A (es) | ||
EA201590732A1 (ru) | Диспергируемая таблетка | |
EA201170950A1 (ru) | Новая комбинация активных ингредиентов, содержащая нестероидное противовоспалительное лекарственное средство и производное колхикозида | |
TR200900880A2 (tr) | Tek bir dozaj formunda kombine edilen farmasötik bileşimler. | |
CL2010001172A1 (es) | Composicion farmaceutica solida termoestable que comprende un ingrediente farmaceutico activo de permeabilidad deficiente y al menos una sustancia mejoradora de la permeabilidad, incorporada en forma termoestable en una matriz soluble en agua de un portador soluble en agua; y un proceso para prepararla. | |
CR20150411A (es) | Composiciones farmacéuticas que contienen dexketoprofeno y tramadol | |
TR200806302A2 (tr) | Çözünürlük ve stabilite artırıcı farmasötik formülasyon. | |
TR201008460A1 (tr) | Eslikarbazepinin saşe formülasyonları. | |
AR115942A2 (es) | Composiciones farmacéuticas estables para la administración intratecal de arisulfatasa a y envases que las comprenden | |
GB201007446D0 (en) | Composition for treatment of H.pylori | |
RS54325B1 (en) | PHARMACEUTICAL COMPOUNDS CONTAINING BETA GALACTOSIDASE AND ALPHA GALACTOSIDASE AND THEIR USE FOR THE TREATMENT OF GASTROESOFAGEAL REFLUX DISEASE | |
CR20120465A (es) | Formulaciones mejoradas para ingredientes farmaceuticos activos de permeabilidad deficiente | |
TR201203084A2 (tr) | Sefditoren pivoksil ve klavulanik asit içeren formülasyonlar. |